All Comments by Elliott Mufson

  1. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
  2. Alzheimer's disease in twins.
  3. Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.
  4. Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles.
  5. A cellular mechanism for the neuronal changes underlying Alzheimer's disease.
  6. Aging and Alzheimer's disease: lessons from the Nun Study.
  7. Vascular variant of Alzheimer's disease characterized by severe plaque-like beta protein angiopathy.
  8. Automated identification and quantitative morphometry of the senile plaques of Alzheimer's disease.
  9. Acetylcholine, aging, and Alzheimer's disease.
  10. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells.
  11. Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells.
  12. The mean A beta load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease.
  13. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
  14. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.
  15. ApoE genotype does not affect plasma tPA and PAI-1 antigen levels.